| 000 | 01794 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515045433.0 | ||
| 264 | 0 | _c20070220 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1111/j.1365-2249.2006.03217.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrinkkoetter, P-T | |
| 245 | 0 | 0 |
_aAtorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cDec 2006 |
||
| 300 |
_a524-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aCaspases _xphysiology |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aHeptanoic Acids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aInterleukin-2 Receptor alpha Subunit _xmetabolism |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMonomeric GTP-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 700 | 1 | _aGottmann, U | |
| 700 | 1 | _aSchulte, J | |
| 700 | 1 | _avan der Woude, F J | |
| 700 | 1 | _aBraun, C | |
| 700 | 1 | _aYard, B A | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 146 _gno. 3 _gp. 524-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2249.2006.03217.x _zAvailable from publisher's website |
| 999 |
_c16673234 _d16673234 |
||